A 27-item questionnaire was used to explore the perceptions, knowledge, and opinions of 146 teachers of students with serious emotional disturbance regarding medication used with their students. The results indicated that the student's doctor was perceived as the leading professional responsible for taking steps to have the student on or off medication for behavior disorders. Parents, the school psychologist, and the student's case committee had a moderate degree of influence on such decisions. The doctor and school psychologist were perceived to be responsible for determining the type of assessments used for evaluating drug effects. Teachers rated global impressions as the assessment procedure used most frequently for such evaluations, but suggested that informal teacher diary would be their choice. Hyperactivity and delusions/hallucinations were seen as the behavior disorders that most likely would lead to medication and, to a lesser extent, acting out and aggression. In general, the teachers desired more involvement in drug decisions and better liaison with the doctors. In addition, they uniformly suggested that their preservice and inservice training in matters related to drug treatment was inadequate, and indicated that there was a great need for further training in this area. Changes in current school policies and practices were suggested by the teachers.
Get full access to this article
View all access options for this article.
References
1.
Aman, M.G., & Singh, N.N. (1980). The usefulness of thioridazine for treating childhood disorders: Fact or folklore?American Journal of Mental Deficiency, 84, 331–338.
2.
Aman, M.G., & Singh, N.N. (1988a). Drug prevalence and patterns of drug use, programs to reduce medication use, measurement techniques, and future trends. In M.G. Aman & N.N. Singh (Eds.), Psychopharmacology of the developmental disabilities (pp. 1–28). New York: Springer-Verlag.
3.
Aman, M.G., & Singh, N.N. (1988b). Psychopharmacology of the developmental disabilities. New York: Springer-Verlag.
4.
Aman, M.G., Singh, N.N., & Fitzpatrick, J. (1987). The relationship between nurse characteristics and perceptions of psychotropic medications in residential facilities for the retarded. Journal of Autism and Developmental Disabilities, 17, 511–523.
5.
Aman, M.G., Singh, N.N., & White, A.J. (1987). Caregiver perceptions of psychotropic medication in residential facilities. Research in Developmental Disabilities, 8, 449–465.
6.
Aman, M.G., & White, A.J. (1986). Measures of drug change in mental retardation. In K.D. Gadow (Ed.), Advances in learning and behavioral disabilities (Vol. 5, pp. 157–202). Greenwich, CT: JAI Press.
7.
Bailey, Jr., D.B., Thiele, J.E., Ware, W.B., & Helsel-DeWert, M. (1985). Participation of professionals, paraprofessionals, and direct-care staff members in the interdisciplinary team meeting. American Journal of Mental Deficiency, 89, 437–440.
8.
Brulle, A.R., Barton, L.E., & Foskett, J.J. (1983). Educator/physician interchanges: A survey and suggestions. Education and Training of the Mentally Retarded, 18, 313–317.
9.
Carlson, G.A. (1988). Depression: Pharmacotherapies. In J.L. Matson (Ed.), Handbook of treatment approaches in childhood psychopathology (pp. 345–363). New York: Plenum Press.
10.
Cone, J.D. (1978). The behavioral assessment grid (BAG): A conceptual framework and taxonomy. Behavior Therapy, 9, 882–888.
11.
Courtnage, L. (1982). A survey of state policies on the use of medication in schools. Exceptional Children, 49, 75–77.
12.
Cullinan, D., Gadow, K.D., & Epstein, M.H. (1987). Psychotropic drug treatment among learning-disabled, educable mentally retarded, and seriously emotionally disturbed students. Journal of Abnormal Child Psychology, 15, 469–477.
13.
Epstein, M.H., & Olinger, E. (1987). Use of medication in school programs for behaviorally disordered pupils. Behavioral Disorders, 12, 138–145.
14.
Forness, S.R., & Kavale, K.A. (1988). Psychopharmacologic treatment: A note on classroom effects. Journal of Learning Disabilities, 21, 144–147.
15.
Gadow, K.D. (1982). Problems with students on medication. Exceptional Children, 49, 20–27.
Gadow, K.D. (1986). Children on medication: Epilepsy, emotional disturbance, and adolescent disorders. Boston: College-Hill.
18.
Gadow, K.D., & Kane, K.M. (1983). Administration of medication by school personnel. Journal of School Health, 53, 178–183.
19.
Glaser, B.A., & Morreau, L.E. (1986). Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons. American Journal of Mental Deficiency, 90, 371–379.
20.
Glasspoole, L.A., & Aman, M.G. (1988). Attitudes and knowledge of gerontological nurses toward psychotropic drugs. Gerontologist, 28, 667–671.
21.
Huessy, H.R., & Ruoff, P.A. (1984). Toward a rational drug usage in a state institution for retarded individuals. Psychiatric Journal of the University of Ottawa, 9, 56–58.
22.
Intagliata, J., & Rinck, C. (1985). Psychoactive drug use in public and community residential facilities for mentally retarded persons. Psychopharmacology Bulletin, 21, 268–278.
23.
Johnson, R., Kenney, J., & Davis, J. (1976). Developing school policy for use of stimulant drugs for hyperactive children. School Review, 85, 78–96.
24.
Kinnison, L., & Nimmer, D. (1979). An analysis of policies regulating medication in the schools. Journal of School Health, 49, 280–283.
25.
Lindsey, C., Leibold, S., Ladd, F., & Ownby, R. (1980). Children on medication: A guide for teachers. Rehabilitation Literature, 41, 124–125.
26.
Matson, J.L. (1988). Handbook of treatment approaches in childhood psychopathology. New York: Plenum Press.
27.
Matson, J.L., & Carey, M. (1988). Depression: Psychological therapies. In J.L. Matson (Ed.), Handbook of treatment approaches in childhood psychopathology (pp. 327–344). New York: Plenum Press.
28.
Ross, R.P. (1979). Drug therapy for hyperactivity: Existing practices in physician-school communication. In M.J. Cohen (Ed.), Drugs and the special child (pp. 99–109). New York: Gardner Press.
29.
Siegel, S., & Castellan, Jr., N.J. (1988). Nonparametric statistics for the behavioral sciences (2nd ed.). New York: McGraw-Hill.
30.
Sindelar, P.T., & Meisel, C.J. (1982). Teacher-physician interaction in the treatment of children with behavioral disorders. International Journal of Partial Hospitalization, 1, 271–277.
Singh, N.N., Deitz, D.E.D., Epstein, M.H., & Singh, J. (in press). Social behavior of students who are seriously emotionally disturbed: A quantitative analysis of intervention studies. Behavior Modification.
33.
Singh, N.N., & Repp, A.C. (1988). Current trends in the behavioral and psychophar-macological management of problem behaviors of mentally retarded persons. Irish Journal of Psychology, 9, 362–384.
34.
Singh, N.N., & Winton, A.S.W. (1989). Behavioral pharmacology. In J.K. Luiselli (Ed.), Behavioral medicine and developmental disabilities (pp. 152–179). New York: Springer-Verlag.
35.
Sprague, R., & Gadow, K. (1976). The role of the teacher in drug treatment. School Review, 85, 109–140.
36.
Wilson, D.R., & Prentice-Dunn, S. (1981). Rating scales in the assessment of child behavior. Journal of Clinical Child Psychology, 10, 121–126.
37.
Wilson, J.E., & Sherrets, S.D. (1979). A review of past and current pharmacological intervention in the treatment of emotionally disturbed children and adolescents. Behavioral Disorders, 5, 60–69.
